课题基金 / 基金详情

IGE BINDING PROTEIN IN PATIENTS W/ ALLERGIC DISEASE

IGE BINDING PROTEIN IN PATIENTS W/ ALLERGIC DISEASE
过敏性疾病患者中的 IGE 结合蛋白
批准号:
6307314
负责人:
FU-TONG LIU
金额:
$2.74万
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-12-01 至 2001-02-28

项目摘要

项目成果

FU-TONG LIU的其他基金

相似基金

相关文献

中文摘要
翻译
该方案的目的是研究IgE结合蛋白,现在被称为Galectin-3,在过敏性炎症中的作用。现有数据表明Galectin-3可能是炎症的放大因子。这种蛋白在各种炎症细胞中表达,我们的假设是,由于各种炎症介质的刺激,患有过敏性疾病的人体内Galectin-3表达上调。该议定书由两个具体目标组成。第一个是关于包括哮喘和特应性皮炎在内的过敏性疾病患者血清中Galectin-3水平的定量,第二个是关于过敏性疾病患者炎性细胞中Galectin-3表达的分析。
英文摘要
The purpose of this protocol is to study the role of IgE-binding protein, now known as galectin-3, in allergic inflammation. Existing data suggest that galectin-3 may be an amplifier of imflammation. This protein is expressed in various inflammatory cells and our hypothesis is that galectin-3 is upregulated in individuals with allergic diseases as a result of stimulation by various imflammatory mediators. The protocol cosists of two specific aims. The first deals with the quantitation of the level of galectin-3 in sera of patients with allergic diseases, including asthma and atopic dermatitis, and the second concerns the analysis of the expression of galectin-3 in inflammatory cells from patients with allergic diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
DEVELOPMENT OF NONHUMAN PRIMATE MODELS OF ATOPIC DERMATITIS
Galectin-3 in regulation of allergic skin inflammation
DEVELOPMENT OF NONHUMAN PRIMATE MODELS OF ATOPIC DERMATITIS
Galectin-3 in regulation of allergic skin inflammation
海外基金